Want to see IN:MOL full AI Analyst Report?
Top Page
Meghmani Organics Limited
(MOL)
Select Model
Select Model
Rating:62Neutral
Price Target:
₹68.00
▲(4.95% Upside)
Action:Reiterated
Date:08/25/26
The score is driven by strong technical momentum (price above key moving averages and positive MACD), partially offset by only moderate financial quality due to volatile results and thin current profitability. Valuation also tempers the score, with a ~25.5 P/E looking less compelling given the earnings and cash-flow variability.
Positive Factors
Earnings and Cash Flow Recovery
The return to positive earnings and free cash flow strengthens the company’s operating base and internal funding capacity. If sustained, this recovery can support maintenance investment, reduce dependence on external financing and improve resilience through the business cycle.
Negative Factors
Thin Profitability
Very limited operating and net margins leave little cushion against weaker chemical prices, higher energy costs or production disruption. Thin profitability also constrains retained cash generation and makes sustainable returns dependent on improved pricing, mix or utilization.
Read all positive and negative factors
Positive Factors
Negative Factors
Earnings and Cash Flow Recovery
The return to positive earnings and free cash flow strengthens the company’s operating base and internal funding capacity. If sustained, this recovery can support maintenance investment, reduce dependence on external financing and improve resilience through the business cycle.
Read all positive factors
Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹15.35B
Dividend YieldN/A
Average Volume (3M)53.48K
Price to Earnings (P/E)24.1
Beta (1Y)1.38
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees1,154
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)2.53
Shares Outstanding254,314,210
10 Day Avg. Volume52,595
30 Day Avg. Volume53,476
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)0.60
Price to Sales (P/S)0.43
P/FCF Ratio9.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.8
Revenue Forecast (FY)₹26.10B
Meghmani Organics Limited Business Overview & Revenue Model
Company Description
Meghmani Organics Limited, founded in 1986 and headquartered in Ahmedabad, India, operates as a producer and supplier of an extensive range of pigments and agrochemical products, catering to markets both within India and globally. The company's pi...
How the Company Makes Money
MOL makes money primarily by manufacturing and selling chemicals to domestic and international customers. Its key revenue streams typically include: (1) Agrochemicals: revenue from sales of crop-protection related chemical products, including tech...
Meghmani Organics Limited Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.03B | 21.74B | 21.24B | 15.48B | 25.28B | 24.73B |
| Gross Profit | 6.70B | 5.93B | 8.60B | 5.21B | 4.79B | 10.01B |
| EBITDA | 2.99B | 2.73B | 1.87B | 119.50M | 4.10B | 4.81B |
| Net Income | 642.50M | 287.39M | -106.01M | -1.06B | 2.38B | 3.04B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 30.21B | 30.85B | 30.40B | 31.98B | 27.98B |
| Cash, Cash Equivalents and Short-Term Investments | 264.88M | 264.88M | 227.24M | 330.74M | 1.52B | 117.22M |
| Total Debt | 0.00 | 7.26B | 8.29B | 8.37B | 8.24B | 4.99B |
| Total Liabilities | -15.45B | 14.76B | 15.70B | 15.12B | 15.29B | 13.31B |
| Stockholders Equity | 15.45B | 15.45B | 15.15B | 15.28B | 16.69B | 14.66B |
Cash Flow | ||||||
| Free Cash Flow | 422.76M | 975.10M | -226.88M | -165.29M | -2.61B | -1.79B |
| Operating Cash Flow | 668.34M | 1.43B | 662.22M | 2.50B | 2.04B | 648.32M |
| Investing Cash Flow | -211.79M | -458.42M | 309.70M | -1.78B | -4.18B | -1.33B |
| Financing Cash Flow | -373.49M | -1.04B | -913.88M | -854.77M | 2.34B | 577.19M |
Meghmani Organics Limited Technical Analysis
Positive
64.79
Price Trends
53.75
Positive
52.44
Positive
55.18
Positive
Market Momentum
2.38
Positive
57.89
Neutral
28.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Positive. The current price of 64.79 is above the 20-day moving average (MA) of 58.95, above the 50-day MA of 53.75, and above the 200-day MA of 55.18, indicating a bullish trend. The MACD of 2.38 indicates Positive momentum. The RSI at 57.89 is Neutral, neither overbought nor oversold. The STOCH value of 28.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MOL.
Meghmani Organics Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹71.58B | 11.29 | ― | 1.84% | 18.52% | 49.11% | |
67 Neutral | ₹44.98B | 16.42 | ― | 0.20% | -5.63% | -11.38% | |
62 Neutral | ₹15.35B | 24.09 | ― | ― | ― | ― | |
58 Neutral | ₹490.34B | 23.86 | ― | 0.77% | 12.86% | 72.26% | |
56 Neutral | ₹375.96B | 31.51 | ― | 0.49% | -16.57% | -27.71% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₹15.80B | 14.88 | ― | 0.50% | 17.05% | 9.10% |
* General Sector Average
IN:MOL
Meghmani Organics Limited
60.98
-21.01
-25.63%
IN:DHANUKA
Dhanuka Agritech Limited
975.80
-645.18
-39.80%
IN:IPL
India Pesticides Ltd.
139.40
-71.36
-33.86%
IN:PIIND
PI Industries Limited
2,430.00
-1,313.44
-35.09%
IN:SHARDACROP
Sharda Cropchem Ltd.
783.90
-176.06
-18.34%
IN:UPL
UPL Limited
571.00
-149.88
-20.79%
Meghmani Organics Limited Corporate Events
Meghmani Organics Announces 7th AGM and E-Voting Arrangements
Aug 15, 2026
Meghmani Organics Limited has notified the stock exchanges that it has published newspaper advertisements announcing its seventh Annual General Meeting for the financial year 2025-26. The AGM will be conducted via video conferencing or other audio...
Exchange Seeks Clarity After Volume Surge in Meghmani Organics
Jul 21, 2026
The stock exchange has flagged a significant increase in trading volume for Meghmani Organics Limited and has formally contacted the company to obtain updated, relevant information. The move aims to ensure transparency, safeguard investor interest...
Meghmani Organics Shareholders Clear Amalgamation of Two Wholly Owned Subsidiaries
Jun 9, 2026
Meghmani Organics Limited has reported that equity shareholders have approved a special resolution to amalgamate its wholly owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, with the parent company. The approval fo...
Meghmani Organics Shareholders Weigh NCLT-Driven Amalgamation Scheme
Jun 6, 2026
Meghmani Organics Limited held a National Company Law Tribunal convened meeting of its equity shareholders on June 6, 2026 via video conferencing, in line with MCA and SEBI circulars. The meeting, chaired by an NCLT-appointed advocate, confirmed q...
Meghmani Organics’ secured creditors meet to vote on amalgamation scheme
Jun 6, 2026
Meghmani Organics Limited convened a court-ordered meeting of its secured creditors on June 6, 2026 via video conferencing, under directions from the National Company Law Tribunal, Ahmedabad. The meeting, chaired by advocate Dr. Ajar Rab, confirme...
Meghmani Organics’ Unsecured Creditors Vote on Court-Directed Amalgamation Scheme
Jun 6, 2026
Meghmani Organics convened a court-directed meeting of its unsecured creditors on June 6, 2026, via video conferencing, in line with an order from the National Company Law Tribunal’s Ahmedabad Bench. The meeting was properly constituted with...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.